CMV retinitis. Ocular fluid samples obtained from 10 control uveitis patients were negative for DNA from CMV, VZV, and EBV by PCR. In one of 10 uveitis control samples HSV-1 DNA was detected; antibody analysis did not confirm this. In the uveitis control group, a significant GWq was calculated in one sample for HSV-1 and in another sample for VZV. The cataract control samples were all herpesvirus DNA negative by PCR. Conclusions-To establish the diagnosis of CMV retinitis in AIDS patients, ophthalmoscopic examination is a sensitive method. In confirming a diagnosis in indistinctive cases, application of a PCR assay detecting CMV DNA is a more sensitive method than analysis of locally produced antibodies by calculating a GWq. In clinical non-herpetic uveitis, secondary release of HSV-1 and VZV should be considered requiring additional therapeutic anticipation.
merase chain reaction (PCR) technique and the analysis of intraocularly produced antibodies by calculating a GoldmannWitmer quotient (GWq) as diagnostic assays in the confirmation of a clinically diagnosed cytomegalovirus (CMV) retinitis in a group of unselected AIDS patients. Methods-Eleven samples of undiluted ocular fluid, obtained from nine AIDS patients with a clinically diagnosed CMV retinitis were analysed for the presence of genomic DNA from CMV, HSV-1, VZV, and EBV by PCR. Nine of these samples were analysed for the presence of locally produced IgG antibodies against these herpesviruses by calculating a GWq. Ten samples obtained from patients with various entities of clinical non-herpetic uveitis and 17 samples of aqueous humour obtained at cataract surgery were used as controls. Results-In 10 out of 11 samples from AIDS patients (91%) the presence of CMV DNA was demonstrated. In four out of nine (44%/o) patients this was accompanied by CMV DNA in the blood indicating a CMV viraemia. In one sample, VZV DNA was detected and in another sample both CMV and VZV DNA were detected. No HSV-1 or EBV DNA could be demonstrated in these 11 samples. In contrast, simultaneous analysis of locally produced IgG antibodies against herpesviruses could not confirm the initial diagnosis of CMV retinitis. Ocular fluid samples obtained from 10 control uveitis patients were negative for DNA from CMV, VZV, and EBV by PCR. In one of 10 uveitis control samples HSV-1 DNA was detected; antibody analysis did not confirm this. In the uveitis control group, a significant GWq was calculated in one sample for HSV-1 and in another sample for VZV. The cataract control samples were all herpesvirus DNA negative by PCR. Conclusions-To establish the diagnosis of CMV retinitis in AIDS patients, ophthalmoscopic examination is a sensitive method. In confirming a diagnosis in indistinctive cases, application of a PCR assay detecting CMV DNA is a more sensitive method than analysis of locally produced antibodies by calculating a GWq. In clinical non-herpetic uveitis, secondary release of HSV-1 and VZV should be considered requiring additional therapeutic anticipation.
(BrJ7 Ophthalmol 1996; 80: [235] [236] [237] [238] [239] [240] Cytomegalovirus (CMV) has been recognised as a causative agent in the diagnosis of uveitis by virus culture for 35 years.' CMV retinitis mainly affects immunocompromised patients and predominantly AIDS patients.2-8 Only three cases of CMV retinitis have been reported in apparently healthy individuals. 6 9 10 Clinically, the patients' main complaints are blurred vision, scotoma, and progressive impaired visual acuity, but asymptomatic ocular infections also occur. The extent of the symptoms depends on the location and type of tissue damaged by the inflammatory reaction.5 6 11 Early ophthalmoscopic findings include diffuse granular infiltrates that may mimic cotton wool spots. Later, typical granular haemorrhagic lesions with centrifugal spread, yellow white perivascular infiltrates, retinal oedema, and vascular sheathing can occur. 2 11 Finally, atrophy of the affected retina and the pigment epithelium and fibrosis may become apparent.
In most cases the diagnosis of CMV retinitis is based on clinical examination and findings by ophthalmoscopy which are typical but not always specific. The differential diagnosis of CMV retinitis should include non-infectious cotton wool spots, toxoplasmosis, candidiasis, syphilis, herpes simplex virus (HSV-1), and varicella zoster virus (VZV) retinitis.8 12 In AIDS patients, the diagnosis can be masked by multiple agents co-infecting the retina. For an adequate choice of therapy confirmation of the clinical diagnosis of CMV retinitis by laboratory tests might be required.3 13 Conventional culture of CMV from blood, aqueous, or vitreous fluid can take a long time to grow and it is rarely positive, limiting its consequences for treatment.2 5 A positive blood culture, however, can be helpful in establishing a disseminated CMV infection, which is accompanied by CMV retinitis in 22-48% of AIDS patients.4 1114 The most sensitive method in antibody production analysis in uveitis patients, is calculation of a Goldmann-Witmer quotient (GWq). 15 16 
DNA EXTRACTION AND PCR
To enhance the efficacy of the PCR assay we purified the target DNA from both ocular fluid and blood samples. 14 26 27 Briefly, DNA was extracted from 100 ,ul of undiluted ocular fluid stored in 1 ml lysis buffer A (4 M guanidineiso-thiocyanate/0-1 M Tris-HCl pH 6 4/44 mM EDTA/2-5 ml per 100 ml Triton X-100).28 A total of 40 RI Celite solution (2 g/ml, Jansen Chemika, the Netherlands) was added and the suspension was incubated for 10 minutes at room temperature to adsorb the DNA. The Celite pellet was washed twice with lysis buffer B (4 M guanidine-isothiocyanate/0 1 M Tris-HCl pH 6 4), twice with 70% ethanol, and once with acetone. The pellet was dried for 15 minutes in a vacuum exsiccator and resuspended in 200 [LI water at 56'C. After 2 minutes of centrifugation (15 000 g), 180 ,ul of the supematant containing the DNA was collected.
A volume of 500 ,ul of the EDTA blood samples was suspended in 9*5 ml lysis buffer A. The DNA was isolated, using 300 ,ul of this suspension, by means of a phenol/ chloroform/isoamyl alcohol extraction and ethanol precipitation. The DNA pellet was resuspended in 200 ,u water. The PCR assays were performed detecting DNA from CMV, HSV-1, VZV, Epstein-Barr virus (EBV), and a human 1 globin sequence. The PCR assay detecting the human 1 globin sequence was used to verify the integrity of the target DNA and the yield of extraction method. The sequences of the primers and probes for CMV, HSV-1, VZV, and ,B globin have been published previously.24 2932 For detection of the HSV-1 DNA, the outer primers were used. For the CMV primers we used a single base modification ofthe originally published sequence ofthe 3'-primer in which at the 3'-terminal end, a Eleven ocular fluid samples of group A patients were analysed for the presence of DNA sequences of the herpesviruses and the human P globin gene (Table 2 ). In 10 of 11 samples CMV DNA was detected. One sample was positive for both CMV and VZV DNA (A5) and another (A6) was only positive for VZV DNA. Genomic DNA from EBV or HSV-1 was not detected in any of the 11 samples. In all samples the human P globin DNA sequence could be detected. The blood samples of the CMV retinitis patients showed detectable CMV DNA in four patients (A2, A4, A7, A8, Table 2 ). In two patients, two blood samples were examined for CMV DNA over a time span of 1 month. In both cases the first and second sample were CMV DNA positive despite antiviral medication.
The ocular fluid samples of the control group B showed no detectable CMV, VZV or EBV DNA (Table 2 ). In one of 10 samples, HSV-1 DNA was detected (Bi). No CMV DNA was detected in the whole blood samples of the control group B. In the aqueous of the 17 cataract patients no herpesvirus DNA was detected. In all control samples the 3 globin DNA was detected. All the analysed sera and the ocular fluid samples of group A patients had positive antibody titres against HSV-1, VZV, and EBV (Table 3 ). In eight of nine (89%) tested ocular fluid samples, IgG anti-CMV antibodies were detected. The GWq was calculated on nine samples of ocular fluid of group A for CMV, HSV-1, and VZV. A GWq for EBV was calculated on seven samples. In sample A7, a significant GWq was found for CMV as well as for HSV-1 and VZV ( Table 2) . None of the samples of group A had a significant GWq for any of the tested herpesviruses although intraocular antibodies against herpesviruses were present (Table 3) .
In the control group B, paired serum and ocular fluid samples were obtained from all 10 patients. Patient B4 had a serum titre lower than 1:16 for HSV-1 ( Table 3 ). All other patients tested had positive serum antibody titres for all herpesviruses -that is, equal or larger than 1:16. In group B, four of seven (57%) ocular fluid samples tested for CMV had a positive antibody titre. For HSV-1 this was nine of 10 (90%/o), for VZV six of 10 (60%), and for EBV this was five of eight (63%). No sample of the control group B showed a significant GWq for CMV and EBV. One sample (B2) showed a significant GWq for HSV-1. Another sample (B3) showed a significant GWq for VZV (Table 2) .
Discussion
This report compares the results of analysis of local antibody production against herpesviruses and PCR assays, detecting DNA of herpesviruses in ocular fluid, in relation to the clinical diagnosis of CMV retinitis in unselected cases in AIDS patients. The clinical diagnosis could not be confirmed in nine of the tested cases by a significant GWq. Compared with the PCR assays the clinical diagnosis of CMV retinitis showed a sensitivity of 100% and a specificity of 91%.
In comparing both types of assays one should consider the basic differences in technique. The PCR assay is a test, detecting directly a part of the virus. The analysis of antibody production, however, is an indirect test, depending on an immunological response of the host against the virus, which is normally reflected in a rise of the antibody titre, but affected in AIDS patients.
The results of the very specific and sensitive PCR technique require a well balanced interpretation, especially in analysing viruses of the herpes family such as CMV, HSV-1, VZV, and EBV. These viruses can establish latent infections in humans and since all patients tested have detectable serum IgG antibodies against all herpesviruses, except patient B4, who had an antibody titre less than 1:16 for HSV-1, they are expected to be carriers of these viruses. However, the aqueous samples of 17 cataract patients were all negative for herpesvirus DNA, indicating that normally no herpesvirus is present in ocular fluid of non-inflamed eyes.
An inflammatory reaction as in uveitis can be a trigger for secondary release of latent herpesviruses and lead to clinically false positive PCR results if detection of the primary pathogen is intended. In ocular fluids from the uveitis control patients, no DNA from the neurotrophic latent VZV or the lymphocytotrophic latent EBV and CMV was detected. This indicates that no positive PCR results were caused by herpesviruses released from latently infected sensory nerve endings, lymphocytes, or vascular endothelium cells.
In group A the role of VZV as a co-infectant or primary pathogen was anticipated. In patient A5, for instance, both CMV DNA and VZV DNA were detected. The ophthalmoscopic features were, however, indicative of a CMV retinitis and lacked a pronounced retinal necrosis. Sample A6, on the other hand, was CMV DNA negative but VZV DNA was positive. In this case, ophthalmoscopic and clinical features were indecisive. The results of the PCR assays indicated an acute retinal necrosis syndrome was more likely and after additive acyclovir therapy the process was halted temporarily. In one uveitis control sample (B1), HSV-1 DNA was found and secondary HSV release must be considered. This patient was suffering from a recurrently eliciting iridocyclitis and a low grade endophthalmitis for 1-5 years after a cataract extraction with lens implantation. Initially, the inflammation responded well to antibiotic and steroid therapy. Later, removal of the implant lens and vitrectomy were necessary. Bacterial cultures of the vitreous fluid were negative and the GWq for CMV, HSV-1, and VZV were insignificant. The insignificant GWq for HSV-1 can be due to wrong time of sampling or to extinction of the immune response after frequent stimulation leading to an absence in rise in antibody production, especially of the IgG class, as has been documented in patients repeatedly suffering from recurrent herpetic infections. '8 33 In AIDS patients a CMV viraemia with leakage of viral particles through the bloodretinal barrier might lead to clinically false positive PCR results in ocular fluid. To exclude this, detection of CMV DNA in blood served as a control. Five out of nine blood samples of group A were CMV DNA negative indicating that CMV DNA in the paired ocular fluid did not originate from the blood. Regarding the paired samples being obtained several weeks after onset of the CMV retinitis the results do not exclude intraocular CMV particles originating from a previous viraemia. It is, however, remarkable that despite prolonged intravenous antiviral therapy four blood samples were CMV DNA negative whereas the corresponding ocular fluid samples were positive and retrospectively confirming the clinical diagnosis. Since clearance of the virus is not only depending on virustatic therapy but also on a functional immune response, the absence of CMV DNA in these blood samples might reflect a residual immune function (three of the four patients had CD4+ counts between 30 and 80 cells x 106/1) combined with a poor penetration of the antiviral medication through the bloodretinal barrier. Resolution of detectable CMV DNA in blood after antiviral therapy has been reported earlier. '4 Control uveitis samples showed no significant GWq for CMV and thus no false positive results were found. In group A also no confirmation of the initial diagnosis of CMV retinitis was demonstrated by a positive GWq. Although minimal use of antibody based assays in AIDS patients might be expected, all but one ocular fluid sample of AIDS patients proved to contain CMV DNA and anti-CMV antibodies, and all sera were anti-CMV IgG or CMV DNA positive or both. Theoretically an inconclusive GWq must result from the insufficient absolute or relative rise of local antibody production. In group A cases an insufficient absolute rise of local antibody production against CMV is likely to be caused by an impaired antibody production as has been described in the later stage of AIDS, both in quantity and quality, and in cytotoxic reaction.2' This can be expected because of the low CD4+ counts. An insufficient relative rise in local antibody production can result from leakage of antibodies through the blood-retinal barrier due to a destructive inflammatory reaction. Furthermore, an overwhelming presence of antigen in the eye might capture the intraocular antibodies, restraining them from analysis. The ratio of antibody titres in calculating a GWq can further be disturbed by relatively high serum IgG antibody titres against CMV, caused by an actual or recent CMV viraemia and high total IgG levels, as is frequently observed in AIDS patients.2' Confusingly, sample A7 showed a significant GWq for CMV, HSV-1, and VZV whereas only CMV DNA was found. Here a possibly aspecific polyclonal antibody production or a co-infection might have led to an indecisive GWq.18 Two samples of the control group (B2, B3) showed a significant GWq, indicating a possible pathogenic role for these viruses. Patient B2 showed a significant GWq for HSV-1 but the PCR assay was negative. This patient was suffering from a systemic lupus erythematosus and was treated continuously with prednisone. A vitrectomy was performed and vitreous fluid was cultured and found positive for Candida tropicalis, which responded well to antimycotic therapy. A significant GWq for VZV was found in a patient (B3) suffering from a low grade endophthalmitis for 1 month after cataract extraction with lens implantation which responded well to antibiotic therapy. Vitreous fluid was culture positive for Staphylococcus epidermidis. A relapse 3 weeks after surgery was treated successfully with acyclovir as aqueous showed a significant GWq for VZV. A second relapse occurred within a week after cessation of acyclovir therapy. Removal of the intraocular implant lens prevented further relapses. The absence of viral DNA seems similar to the negative PCR results in the course of herpes simplex encephalitis, perhaps as a result of late timing of obtaining the sample, especially when it concerns immune competent patients basically capable of clearing the virus.34
In conclusion, ophthalmoscopic examination is a sensitive method for the clinical diagnosis of CMV retinitis in unselected cases in AIDS patients. In indistinctive cases confirmation of the diagnosis of CMV retinitis by detecting CMV DNA in ocular fluid using a PCR assay is a more sensitive tool than analysis of locally produced antibodies. The herpesvirus PCR assays can support the choice of therapy in atypical clinical cases. In the case of a clinical non-herpetic, active uveitis the' role of secondary released HSV-1 or VZV should be considered, possibly requiring additional therapeutic anticipation. Since no postoperative complications were observed, anterior chamber paracentesis is a safe method to obtain clinical samples for laboratory analysis.
In future studies, the value of PCR assays for other aetiological agents in infectious uveitis and other patient groups must be established. Moreover, efforts should be made to enhance the efficacy of the PCR assays in ophthalmology, and to develop standardised protocols and intercentre quality control programmes allowing better comparison of the results of different studies. 
